| Bioactivity | ERAP2-IN-1 (compound 61) is an uncompetitive ERAP2 inhibitor. ERAP2-IN-1 specifically inhibits the ERAP2 peptide hydrolysis activity, inhibiting Arg-AMC hydrolysis with an IC50 of 27 μM and model peptide hydrolysis with an IC50 of 44 μM[1]. | |||||||||
| Name | ERAP2-IN-1 | |||||||||
| CAS | 2420551-38-6 | |||||||||
| Formula | C20H21F3N2O5S | |||||||||
| Molar Mass | 458.45 | |||||||||
| Appearance | Solid | |||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | |||||||||
| Storage |
|
|||||||||
| Reference | [1]. Arya R, et al. Phenylsulfamoyl Benzoic Acid Inhibitor of ERAP2 with a Novel Mode of Inhibition. ACS Chem Biol. 2022 Jun 29. |
ERAP2-IN-1
CAS: 2420551-38-6 F: C20H21F3N2O5S W: 458.45
ERAP2-IN-1 (compound 61) is an uncompetitive ERAP2 inhibitor. ERAP2-IN-1 specifically inhibits the ERAP2 peptide hydroly
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.